Structure of Rosiglitazone
CAS No.: 122320-73-4
*Storage: {[sel_prStorage]}
*Shipping: {[sel_prShipping]}
The BI-3802 was designed by Boehringer Ingelheim and could be obtained free of charge through the Boehringer Ingelheim open innovation portal opnMe.com, associated with its negative control.
Rosiglitazone is a selective peroxisome proliferator-activated receptor γ (PPAR-γ) agonist with high affinity for PPAR-γ, with an EC50 value of 60 nM. Rosiglitazone exhibits hypoglycemic and anti-inflammatory effects and is widely used in the research and treatment of type 2 diabetes.
Synonyms: BRL 49653
4.5
*For Research Use Only !
Change View
Size | Price | VIP Price | US Stock |
Global Stock |
In Stock | ||
{[ item.pr_size ]} |
Inquiry
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.discount_usd) ]} {[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]} |
Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]} | Inquiry {[ item.pr_usastock ]} In Stock Inquiry - | {[ item.pr_chinastock ]} {[ item.pr_remark ]} In Stock 1-2 weeks - Inquiry - | Login | - + | Inquiry |
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days
1-2weeks
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd,1,item.mem_rate,item.pr_is_large_size_no_price, item.pr_usd) ]}
Inquiry
{[ getRatePrice(item.pr_usd,item.pr_rate,1,item.pr_is_large_size_no_price, item.vip_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
{[ getRatePrice(item.pr_usd, 1,1,item.pr_is_large_size_no_price, item.pr_usd) ]}
In Stock
- +
Please Login or Create an Account to: See VIP prices and availability
US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
CAS No. : | 122320-73-4 |
Formula : | C18H19N3O3S |
M.W : | 357.43 |
SMILES Code : | CN(CCOC1=CC=C(CC2SC(=O)NC2=O)C=C1)C1=NC=CC=C1 |
Synonyms : |
BRL 49653
|
MDL No. : | MFCD00871760 |
InChI Key : | YASAKCUCGLMORW-UHFFFAOYSA-N |
Pubchem ID : | 77999 |
GHS Pictogram: |
![]() |
Signal Word: | Warning |
Hazard Statements: | H315-H319-H335 |
Precautionary Statements: | P261-P305+P351+P338 |
Description |
Rosiglitazone, identified as BRL 49653, acts as a selective agonist for PPARγ with an EC50 of 60 nM and a Kd of 40 nM. It also functions as a TRPC5 activator and a TRPM3 inhibitor, making it relevant for research into obesity, diabetes, cellular senescence, and ovarian cancer[1].[2].[4].[7].
|
In Vitro:
Concentration | Treated Time | Description | References |
Mouse mandibular mesenchymal stem cells (OMSCs) | 1 μM | 2 days | Induced OMSCs to differentiate into adipocytes, and Oil Red O staining was used to detect lipid accumulation. | PMC7162802 |
3T3-L1 cells | 1 μM | Rosiglitazone treatment upregulated HSPA12A expression in undifferentiated 3T3-L1 cells, indicating the regulatory effect of PPARγ activator on HSPA12A expression. | PMC6888823 | |
3T3-L1 preadipocytes | 2 μM | 3 days | Induce differentiation of 3T3-L1 preadipocytes into adipocytes | PMC9192799 |
white adipocytes | 1 μM | 48 h | Induce differentiation of white adipocytes | PMC7211001 |
brown adipocytes | 1 μM | 2 days | Induce differentiation of brown adipocytes | PMC7211001 |
3T3-L1 cells | 1 µM | 36-48 h | To study the effect of rosiglitazone on TUSC5 protein levels, results showed that rosiglitazone treatment increased TUSC5 protein levels. | PMC4632119 |
Immortalized brown preadipocytes | 1 nM | 2 days | To study the effect of rosiglitazone on TUSC5 protein levels in PPARγ-knockdown brown preadipocytes, results showed that TUSC5 protein levels were reduced after PPARγ knockdown. | PMC4632119 |
In Vivo:
Administration | Dosage | Frequency | Description | References |
Mice | High-fat diet-induced meibomian gland inflammation model | Intraperitoneal injection | 10 mg/kg/d | Once daily for 4 weeks | Rosiglitazone alleviated high-fat diet-induced meibomian gland inflammation by upregulating PPAR-γ expression, reducing pro-inflammatory cytokine expression, and inhibiting MAPK and NF-κB signaling pathways. | PMC8374999 |
Mice | High-fat diet-induced insulin resistance model | Oral gavage | 10 mg/kg | Daily for 2 weeks | To study the effect of rosiglitazone on blood glucose and insulin levels in TUSC5 knockout and wild-type mice, results showed that rosiglitazone significantly reduced blood glucose and insulin levels in wild-type mice, but this effect was significantly blunted in TUSC5 knockout mice. | PMC4632119 |
Mice | Experimental dermal fibrosis model | Oral gavage | 5 mg/kg | Once daily for 3 weeks | To evaluate the preventive effect of Rosiglitazone on dermal fibrosis, results showed that Rosiglitazone significantly reduced dermal thickness and collagen deposition. | PMC5136696 |
Mice | High-fat diet-induced obese mouse model | Food admixture | 0.1 mg/kg | Once daily for 15 days | To investigate the effect of iNOS gene disruption on the metabolic actions of rosiglitazone in obese mice. Results showed that rosiglitazone improved glucose tolerance and liver insulin signaling only in obese mice lacking iNOS, and significantly raised plasma adiponectin levels. | PMC2494686 |
Clinical Trial:
NCT Number | Conditions | Phases | Recruitment | Completion Date | Locations |
NCT00143624 | Atherosclerosis ... More >> HIV Infections Less << | Not Applicable | Completed | - | Canada, British Columbia ... More >> St. Paul's Hospital Vancouver, British Columbia, Canada, V6Z 1Y6 Less << |
NCT00116831 | Atherosclerosis | Phase 3 | Completed | - | - |
NCT01060566 | Cystic Fibrosis | Phase 1 | Completed | - | United States, Florida ... More >> Covan CRU, Inc. Daytona Beach, Florida, United States, 32117 Less << |
NCT00169923 | Chronic Kidney Disease ... More >> Inflammation Less << | Phase 2 Phase 3 | Withdrawn(it was not possible ... More >>to recruit any patient in the study) Less << | May 2009 | Netherlands ... More >> Medisch Centrum Haaglanden Den Haag, Z-Holland, Netherlands, 2512va Haga Ziekenhuis Den Haag, Z-Holland, Netherlands, 2545ch Less << |
NCT00116831 | - | Completed | - | - | |
NCT00154011 | Healthy Subjects | Not Applicable | Completed | - | Germany ... More >> Institute of Clinical Pharmacology Dresden, Germany, 01307 Less << |
NCT00567593 | Inflammatory Bowel Disease | PHASE4 | COMPLETED | 2025-03-08 | University of Pennsylvania Cli... More >>nical and Translational Research Center, Philadelphia, Pennsylvania, 19104, United States Less << |
NCT01088594 | Type 2 Diabetes Mellitus | Phase 1 | Completed | - | United Kingdom ... More >> S337.1.004 Site # London, United Kingdom Less << |
NCT00567593 | Inflammatory Bowel Disease | PHASE4 | COMPLETED | 2025-03-08 | University of Pennsylvania Cli... More >>nical and Translational Research Center, Philadelphia, Pennsylvania, 19104, United States Less << |
NCT01402076 | Healthy Volunteers | Phase 1 | Completed | - | United States, Missouri ... More >> Bio-Kinetic Clinical Applications Springfield, Missouri, United States, 65802 Less << |
NCT00166803 | Diabetes Mellitus, Atheroscler... More >>osis Less << | SUSPENDED | - | National Taiwan University Hos... More >>pital, Taipei, 10012, Taiwan Less << | |
NCT00367055 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | - |
NCT00098852 | Head and Neck Cancer | Phase 2 | Unknown | - | United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less << |
NCT00372086 | Type 1 Diabetes|Puberty: >Tann... More >>er 2 Breast Development or Testis >4ml Less << | PHASE4 | COMPLETED | 2025-09-05 | Sydney Children's Hospital, Sy... More >>dney, New South Wales, 2038, Australia Less << |
NCT00318630 | Asthma | Phase 1 | Completed | - | New Zealand ... More >> GSK Investigational Site Wellington, New Zealand, 6035 Less << |
NCT00115661 | Endometriosis | PHASE2 | TERMINATED | 2025-05-06 | University of Michigan Health ... More >>System, Ann Arbor, Michigan, 48109, United States Less << |
NCT00225225 | Diabetes Mellitus, Type 2 | Not Applicable | Terminated(due to published da... More >>ta on Rosiglitazone) Less << | - | United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less << |
NCT00309309 | Kidney Transplant | PHASE2 | COMPLETED | 2025-07-07 | Clinical Research Center for R... More >>are Diseases, Ranica, Bergamo, 24020, Italy Less << |
NCT00831129 | Pre-diabetes | Phase 2 Phase 3 | Completed | - | United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less << |
NCT00492700 | Non Alcoholic Steatohepatitis | Phase 2 | Completed | - | France ... More >> Service d'hépatogastroenérologie, Hôpital Pitié Salpêtrière Paris, France, 75013 Less << |
NCT00953498 | Type 2 Diabetes | Phase 4 | Completed | - | France ... More >> Service Endocrinologie-diabétologie, Hôpital du Bocage CHU Dijon, France, 21000 Less << |
NCT00367055 | - | Completed | - | - | |
NCT00130286 | HIV-Associated Lipodystrophy S... More >>yndrome Insulin Resistance HIV Infections Metabolic Syndrome X Body Weight Changes Less << | Phase 1 Phase 2 | Completed | - | United States, New York ... More >> AIDS Community Research Initiative of America (ACRIA) New York, New York, United States, 10018 Cornell HIV Clinical Trials Unit, Weill Medical College of Cornell University New York, New York, United States, 10021 St. Luke's-Roosevelt Hospital Center New York, New York, United States, 10025 Columbia University College of Physicians and Surgeons New York, New York, United States, 10032 Less << |
NCT00364221 | Metabolic Syndrome|Insulin Res... More >>istance Less << | PHASE4 | COMPLETED | 2025-10-06 | University of Colorado at Denv... More >>er and Health Sciences Center General Clinical Research Center, Denver, Colorado, 80262, United States Less << |
NCT00123643 | Type 2 Diabetes Mellitus | Phase 4 | Completed | - | United States, Minnesota ... More >> St. Paul Heart Clinic St. Paul, Minnesota, United States, 55102 Less << |
NCT00130286 | - | Completed | - | - | |
NCT00452166 | Chronic Kidney Disease ... More >> Insulin Resistance Less << | Phase 3 | Terminated(it was not possible... More >> to recruit new patients anymore) Less << | - | Netherlands ... More >> LUMC Leiden, Netherlands Less << |
NCT00831129 | - | Completed | - | - | |
NCT00123643 | - | Completed | - | - | |
NCT00522470 | Type 2 Diabetes Mellitus ... More >> Obesity Less << | Phase 4 | Completed | - | Turkey ... More >> Baskent University Hospital Department of Endocrinology Ankara, Bahçelievler, Turkey, 06490 Less << |
NCT00324675 | Type 2 Diabetes ... More >> Overt Diabetic Nephropathy Less << | Not Applicable | Completed | - | Germany ... More >> University hospital Dresden Dresden, Germany, 01307 Less << |
NCT00348140 | Alzheimer's Disease | Phase 3 | Completed | - | - |
NCT00484419 | Type 2 Diabetes ... More >> Hyperlipidemia Less << | Phase 3 | Completed | - | United States, California ... More >> La Mesa, California, United States Los Angeles, California, United States Los Gatos, California, United States San Antonio, California, United States United States, Florida Chiefland, Florida, United States United States, Indiana Gary, Indiana, United States United States, Maryland Baltimore, Maryland, United States United States, Michigan Dearborn, Michigan, United States W. Bloomfield, Michigan, United States United States, Nevada Las Vegas, Nevada, United States United States, New York Yonkers, New York, United States United States, North Carolina Lexington, North Carolina, United States Winston-Salem, North Carolina, United States United States, Ohio Munroe Falls, Ohio, United States Zaneville, Ohio, United States United States, Oregon Portland, Oregon, United States United States, Pennsylvania Jersey Shore, Pennsylvania, United States United States, South Carolina Clemson, South Carolina, United States United States, Tennessee Harriman, Tennessee, United States United States, Texas Dallas, Texas, United States Less << |
NCT00379769 | - | Completed | - | - | |
NCT00324675 | - | Completed | - | - | |
NCT00306644 | Diabetes Mellitus, Type 2 | PHASE4 | COMPLETED | 2025-11-04 | GSK Investigational Site, Malm... More >>?, SE-205 02, Sweden Less << |
NCT00484419 | - | Completed | - | - | |
NCT00348140 | - | Completed | - | - | |
NCT00499707 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00675740 | Impaired Glucose Tolerance | Phase 4 | Completed | - | - |
NCT00314561 | Metabolic Syndrome | Phase 4 | Completed | - | Korea, Republic of ... More >> Korea University Anam Hospital Seoul, Korea, Republic of, 136-705 Less << |
NCT00123227 | Diabetes Mellitus, Type 2|Vasc... More >>ular Diseases|Hypertension Less << | PHASE3 | UNKNOWN | 2025-05-05 | Cardiovascular Magnetic Resona... More >>nce Unit, Royal Brompton Hospital, London, SW3 6NP, United Kingdom|St Mary's NHS Trust, London, W2 1NY, United Kingdom Less << |
NCT00551564 | Diabetes Mellitus, Type 2 | Phase 1 | Completed | - | United States, California ... More >> GSK Investigational Site Chula Vista, California, United States, 91911 Less << |
NCT00285142 | Healthy | Not Applicable | Completed | - | France ... More >> Centre d'Investigation Clinique Montpellier, France, 34295, cedex 5 Less << |
NCT00511823 | Nausea and Vomiting, Chemother... More >>apy-Induced Less << | Phase 1 | Completed | - | United States, Indiana ... More >> GSK Investigational Site Evansville, Indiana, United States, 47714 Less << |
NCT00194896 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | United States, Washington ... More >> DVA Puget Sound Health Care System Seattle, Washington, United States, 98108 Less << |
NCT00432679 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | Japan ... More >> GSK Investigational Site Kumamoto, Japan, 862-0976 GSK Investigational Site Oita, Japan, 870-0039 Less << |
NCT00178841 | Cutaneous T-cell Lymphoma ... More >> Mycosis Fungoides Sezary Syndrome Less << | Phase 2 | Completed | - | United States, Tennessee ... More >> Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-5227 Less << |
NCT00379769 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00178841 | - | Completed | - | - | |
NCT00318656 | Non-Insulin-Dependent Diabetes... More >> Mellitus Less << | Phase 4 | Completed | - | - |
NCT00331487 | Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00348309 | - | Completed | - | - | |
NCT01332370 | - | Completed | - | - | |
NCT00318656 | - | Completed | - | - | |
NCT00119496 | Asthma | Phase 2 Phase 3 | Completed | - | United Kingdom ... More >> Asthma Research Group, Gartnavel General Hospital Glasgow, Scotland, United Kingdom, G12 0YN Less << |
NCT00279045 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00194896 | - | Completed | - | - | |
NCT00550420 | Alzheimer's Disease | Phase 3 | Terminated(Based on preliminar... More >>y parent study results) Less << | - | - |
NCT00550420 | - | Terminated(Based on preliminar... More >>y parent study results) Less << | - | - | |
NCT00348309 | Alzheimer's Disease | Not Applicable | Completed | - | - |
NCT00428090 | Alzheimer's Disease | PHASE3 | COMPLETED | 2008-09-05 | GSK Investigational Site, Phoe... More >>nix, Arizona, 85004, United States|GSK Investigational Site, Los Angeles, California, 90036, United States|GSK Investigational Site, Newport Beach, California, 92660, United States|GSK Investigational Site, Palo Alto, California, 94305, United States|GSK Investigational Site, Reseda, California, 91355, United States|GSK Investigational Site, San Diego, California, 92120, United States|GSK Investigational Site, San Francisco, California, 94109, United States|GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, Fairfield, Connecticut, 06824, United States|GSK Investigational Site, Norwalk, Connecticut, 06851, United States|GSK Investigational Site, Deerfield Beach, Florida, 33064, United States|GSK Investigational Site, Delray Beach, Florida, 33445, United States|GSK Investigational Site, Destin, Florida, 32541, United States|GSK Investigational Site, Hialeah, Florida, 33016, United States|GSK Investigational Site, Melbourne, Florida, 32901, United States|GSK Investigational Site, Plantation, Florida, 33317, United States|GSK Investigational Site, Sunrise, Florida, 33351, United States|GSK Investigational Site, Tampa, Florida, 33647, United States|GSK Investigational Site, Atlanta, Georgia, 30033, United States|GSK Investigational Site, St. Paul, Minnesota, 55101, United States|GSK Investigational Site, Las Vegas, Nevada, 89146, United States|GSK Investigational Site, Kenilworth, New Jersey, 07033, United States|GSK Investigational Site, Toms River, New Jersey, 08755, United States|GSK Investigational Site, Albany, New York, 12208, United States|GSK Investigational Site, Syracuse, New York, 13210, United States|GSK Investigational Site, Centerville, Ohio, 45459, United States|GSK Investigational Site, Cleveland, Ohio, 44120, United States|GSK Investigational Site, Cleveland, Ohio, 44195, United States|GSK Investigational Site, Toledo, Ohio, 43623, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73112, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73118, United States|GSK Investigational Site, Tulsa, Oklahoma, 74104, United States|GSK Investigational Site, Jenkintown, Pennsylvania, 19046, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19102, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104, United States|GSK Investigational Site, Memphis, Tennessee, 35105, United States|GSK Investigational Site, Nashville, Tennessee, 37212, United States|GSK Investigational Site, DeSoto, Texas, 75115, United States|GSK Investigational Site, San Antonio, Texas, 78229-3900, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Middleton, Wisconsin, 53562-2215, United States|GSK Investigational Site, Graz-Eggenberg, A-8020, Austria|GSK Investigational Site, Hall in Tirol, A-6060, Austria|GSK Investigational Site, Linz, 4020, Austria|GSK Investigational Site, Linz, A-4020, Austria|GSK Investigational Site, Vienna, 1030, Austria|GSK Investigational Site, Vienna, A-1090, Austria|GSK Investigational Site, Vienna, A-1130, Austria|GSK Investigational Site, Plovdiv, 4000, Bulgaria|GSK Investigational Site, Sofia, 1113, Bulgaria|GSK Investigational Site, Sofia, 1431, Bulgaria|GSK Investigational Site, Sofia, 1527, Bulgaria|GSK Investigational Site, Providencia / Santiago, Región Metro De Santiago, 7500710, Chile|GSK Investigational Site, Puente Alto - Santiago, Región Metro De Santiago, 8207257, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, 7560356, Chile|GSK Investigational Site, Vi?a del Mar, Valparaíso, 252-0997, Chile|GSK Investigational Site, Guangzhou, Guangdong, 510370, China|GSK Investigational Site, Beijing, 100083, China|GSK Investigational Site, Beijing, 100730, China|GSK Investigational Site, Shanghai, 200025, China|GSK Investigational Site, Shanghai, 200030, China|GSK Investigational Site, Shanghai, 200040, China|GSK Investigational Site, Tianjin, 300052, China|GSK Investigational Site, Dubrovnik, 20000, Croatia|GSK Investigational Site, Zagreb, 10000, Croatia|GSK Investigational Site, Tallinn, 10138, Estonia|GSK Investigational Site, Tallinn, 10614, Estonia|GSK Investigational Site, Tallinn, 10617, Estonia|GSK Investigational Site, Tartu, 51014, Estonia|GSK Investigational Site, Ellwangen, Baden-Wuerttemberg, 73479, Germany|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, 72076, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, 89073, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, 89075, Germany|GSK Investigational Site, Guenzburg, Bayern, 89312, Germany|GSK Investigational Site, Muenchen, Bayern, 80331, Germany|GSK Investigational Site, Muenchen, Bayern, 81675, Germany|GSK Investigational Site, Nuernberg, Bayern, 90402, Germany|GSK Investigational Site, Unterhaching, Bayern, 82008, Germany|GSK Investigational Site, Bad Homburg, Hessen, 61348, Germany|GSK Investigational Site, Schwerin, Mecklenburg-Vorpommern, 19053, Germany|GSK Investigational Site, Schwerin, Mecklenburg-Vorpommern, 19055, Germany|GSK Investigational Site, Achim, Niedersachsen, 28832, Germany|GSK Investigational Site, Hannover, Niedersachsen, 30559, Germany|GSK Investigational Site, Baesweiler, Nordrhein-Westfalen, 52499, Germany|GSK Investigational Site, Bielefeld, Nordrhein-Westfalen, 33647, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, 44892, Germany|GSK Investigational Site, Duisburg, Nordrhein-Westfalen, 47051, Germany|GSK Investigational Site, Juelich, Nordrhein-Westfalen, 52428, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50767, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, 06122, Germany|GSK Investigational Site, Chemnitz, Sachsen, 09111, Germany|GSK Investigational Site, Dresden, Sachsen, 01097, Germany|GSK Investigational Site, Dresden, Sachsen, 01307, Germany|GSK Investigational Site, Leipzig, Sachsen, 04103, Germany|GSK Investigational Site, Itzehoe, Schleswig-Holstein, 25524, Germany|GSK Investigational Site, Gera, Thueringen, 07551, Germany|GSK Investigational Site, Berlin, 12163, Germany|GSK Investigational Site, Berlin, 12167, Germany|GSK Investigational Site, Berlin, 13125, Germany|GSK Investigational Site, Berlin, 13507, Germany|GSK Investigational Site, Berlin, 14163, Germany|GSK Investigational Site, Hamburg, 20249, Germany|GSK Investigational Site, Hamburg, 22083, Germany|GSK Investigational Site, Hamburg, 22143, Germany|GSK Investigational Site, Athens, 115 21, Greece|GSK Investigational Site, Melissia, 151 27, Greece|GSK Investigational Site, Thessaloniki, 57010, Greece|GSK Investigational Site, Budapest, 1106, Hungary|GSK Investigational Site, Gyula, 5700, Hungary|GSK Investigational Site, Kaposvár, 7400, Hungary|GSK Investigational Site, Pécs, 7623, Hungary|GSK Investigational Site, Szeged, 6725, Hungary|GSK Investigational Site, Bangalore, 560034, India|GSK Investigational Site, Nagpur, 440010, India|GSK Investigational Site, Tirupati, 517507, India|GSK Investigational Site, Seongnam-si,, 463-707, Korea, Republic of|GSK Investigational Site, Seoul, 143-729, Korea, Republic of|GSK Investigational Site, Saltillo, Coahuila, 25000, Mexico|GSK Investigational Site, Monterrey, Nuevo León, 64660, Mexico|GSK Investigational Site, Mexico, 14000, Mexico|GSK Investigational Site, Auckland, 0622, New Zealand|GSK Investigational Site, Karachi, 74800, Pakistan|GSK Investigational Site, Lahore, 54000, Pakistan|GSK Investigational Site, Lahore, 54590, Pakistan|GSK Investigational Site, Lima, Lima 13, Peru|GSK Investigational Site, Pasig City, 1600, Philippines|GSK Investigational Site, Quezon City, 1102, Philippines|GSK Investigational Site, Cabo Rojo, 623, Puerto Rico|GSK Investigational Site, San Juan, 00918, Puerto Rico|GSK Investigational Site, San Juan, 90660, Puerto Rico|GSK Investigational Site, Moscow, 115522, Russian Federation|GSK Investigational Site, Moscow, 115552, Russian Federation|GSK Investigational Site, Moscow, 117049, Russian Federation|GSK Investigational Site, St. Petersburg, 197022, Russian Federation|GSK Investigational Site, St.-Petersburg, 198103, Russian Federation|GSK Investigational Site, Bradford, BD3 0DQ, United Kingdom|GSK Investigational Site, Derriford, Plymouth, PL6 8BX, United Kingdom|GSK Investigational Site, West of Scotland Science Park, Glasgow, G20 0XA, United Kingdom Less << |
NCT00242619 | - | Completed | - | - | |
NCT00428090 | Alzheimer's Disease | PHASE3 | COMPLETED | 2008-09-05 | GSK Investigational Site, Phoe... More >>nix, Arizona, 85004, United States|GSK Investigational Site, Los Angeles, California, 90036, United States|GSK Investigational Site, Newport Beach, California, 92660, United States|GSK Investigational Site, Palo Alto, California, 94305, United States|GSK Investigational Site, Reseda, California, 91355, United States|GSK Investigational Site, San Diego, California, 92120, United States|GSK Investigational Site, San Francisco, California, 94109, United States|GSK Investigational Site, Denver, Colorado, 80218, United States|GSK Investigational Site, Fairfield, Connecticut, 06824, United States|GSK Investigational Site, Norwalk, Connecticut, 06851, United States|GSK Investigational Site, Deerfield Beach, Florida, 33064, United States|GSK Investigational Site, Delray Beach, Florida, 33445, United States|GSK Investigational Site, Destin, Florida, 32541, United States|GSK Investigational Site, Hialeah, Florida, 33016, United States|GSK Investigational Site, Melbourne, Florida, 32901, United States|GSK Investigational Site, Plantation, Florida, 33317, United States|GSK Investigational Site, Sunrise, Florida, 33351, United States|GSK Investigational Site, Tampa, Florida, 33647, United States|GSK Investigational Site, Atlanta, Georgia, 30033, United States|GSK Investigational Site, St. Paul, Minnesota, 55101, United States|GSK Investigational Site, Las Vegas, Nevada, 89146, United States|GSK Investigational Site, Kenilworth, New Jersey, 07033, United States|GSK Investigational Site, Toms River, New Jersey, 08755, United States|GSK Investigational Site, Albany, New York, 12208, United States|GSK Investigational Site, Syracuse, New York, 13210, United States|GSK Investigational Site, Centerville, Ohio, 45459, United States|GSK Investigational Site, Cleveland, Ohio, 44120, United States|GSK Investigational Site, Cleveland, Ohio, 44195, United States|GSK Investigational Site, Toledo, Ohio, 43623, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73112, United States|GSK Investigational Site, Oklahoma City, Oklahoma, 73118, United States|GSK Investigational Site, Tulsa, Oklahoma, 74104, United States|GSK Investigational Site, Jenkintown, Pennsylvania, 19046, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19102, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19104, United States|GSK Investigational Site, Memphis, Tennessee, 35105, United States|GSK Investigational Site, Nashville, Tennessee, 37212, United States|GSK Investigational Site, DeSoto, Texas, 75115, United States|GSK Investigational Site, San Antonio, Texas, 78229-3900, United States|GSK Investigational Site, San Antonio, Texas, 78229, United States|GSK Investigational Site, Middleton, Wisconsin, 53562-2215, United States|GSK Investigational Site, Graz-Eggenberg, A-8020, Austria|GSK Investigational Site, Hall in Tirol, A-6060, Austria|GSK Investigational Site, Linz, 4020, Austria|GSK Investigational Site, Linz, A-4020, Austria|GSK Investigational Site, Vienna, 1030, Austria|GSK Investigational Site, Vienna, A-1090, Austria|GSK Investigational Site, Vienna, A-1130, Austria|GSK Investigational Site, Plovdiv, 4000, Bulgaria|GSK Investigational Site, Sofia, 1113, Bulgaria|GSK Investigational Site, Sofia, 1431, Bulgaria|GSK Investigational Site, Sofia, 1527, Bulgaria|GSK Investigational Site, Providencia / Santiago, Región Metro De Santiago, 7500710, Chile|GSK Investigational Site, Puente Alto - Santiago, Región Metro De Santiago, 8207257, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, 7560356, Chile|GSK Investigational Site, Vi?a del Mar, Valparaíso, 252-0997, Chile|GSK Investigational Site, Guangzhou, Guangdong, 510370, China|GSK Investigational Site, Beijing, 100083, China|GSK Investigational Site, Beijing, 100730, China|GSK Investigational Site, Shanghai, 200025, China|GSK Investigational Site, Shanghai, 200030, China|GSK Investigational Site, Shanghai, 200040, China|GSK Investigational Site, Tianjin, 300052, China|GSK Investigational Site, Dubrovnik, 20000, Croatia|GSK Investigational Site, Zagreb, 10000, Croatia|GSK Investigational Site, Tallinn, 10138, Estonia|GSK Investigational Site, Tallinn, 10614, Estonia|GSK Investigational Site, Tallinn, 10617, Estonia|GSK Investigational Site, Tartu, 51014, Estonia|GSK Investigational Site, Ellwangen, Baden-Wuerttemberg, 73479, Germany|GSK Investigational Site, Tuebingen, Baden-Wuerttemberg, 72076, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, 89073, Germany|GSK Investigational Site, Ulm, Baden-Wuerttemberg, 89075, Germany|GSK Investigational Site, Guenzburg, Bayern, 89312, Germany|GSK Investigational Site, Muenchen, Bayern, 80331, Germany|GSK Investigational Site, Muenchen, Bayern, 81675, Germany|GSK Investigational Site, Nuernberg, Bayern, 90402, Germany|GSK Investigational Site, Unterhaching, Bayern, 82008, Germany|GSK Investigational Site, Bad Homburg, Hessen, 61348, Germany|GSK Investigational Site, Schwerin, Mecklenburg-Vorpommern, 19053, Germany|GSK Investigational Site, Schwerin, Mecklenburg-Vorpommern, 19055, Germany|GSK Investigational Site, Achim, Niedersachsen, 28832, Germany|GSK Investigational Site, Hannover, Niedersachsen, 30559, Germany|GSK Investigational Site, Baesweiler, Nordrhein-Westfalen, 52499, Germany|GSK Investigational Site, Bielefeld, Nordrhein-Westfalen, 33647, Germany|GSK Investigational Site, Bochum, Nordrhein-Westfalen, 44892, Germany|GSK Investigational Site, Duisburg, Nordrhein-Westfalen, 47051, Germany|GSK Investigational Site, Juelich, Nordrhein-Westfalen, 52428, Germany|GSK Investigational Site, Koeln, Nordrhein-Westfalen, 50767, Germany|GSK Investigational Site, Halle, Sachsen-Anhalt, 06122, Germany|GSK Investigational Site, Chemnitz, Sachsen, 09111, Germany|GSK Investigational Site, Dresden, Sachsen, 01097, Germany|GSK Investigational Site, Dresden, Sachsen, 01307, Germany|GSK Investigational Site, Leipzig, Sachsen, 04103, Germany|GSK Investigational Site, Itzehoe, Schleswig-Holstein, 25524, Germany|GSK Investigational Site, Gera, Thueringen, 07551, Germany|GSK Investigational Site, Berlin, 12163, Germany|GSK Investigational Site, Berlin, 12167, Germany|GSK Investigational Site, Berlin, 13125, Germany|GSK Investigational Site, Berlin, 13507, Germany|GSK Investigational Site, Berlin, 14163, Germany|GSK Investigational Site, Hamburg, 20249, Germany|GSK Investigational Site, Hamburg, 22083, Germany|GSK Investigational Site, Hamburg, 22143, Germany|GSK Investigational Site, Athens, 115 21, Greece|GSK Investigational Site, Melissia, 151 27, Greece|GSK Investigational Site, Thessaloniki, 57010, Greece|GSK Investigational Site, Budapest, 1106, Hungary|GSK Investigational Site, Gyula, 5700, Hungary|GSK Investigational Site, Kaposvár, 7400, Hungary|GSK Investigational Site, Pécs, 7623, Hungary|GSK Investigational Site, Szeged, 6725, Hungary|GSK Investigational Site, Bangalore, 560034, India|GSK Investigational Site, Nagpur, 440010, India|GSK Investigational Site, Tirupati, 517507, India|GSK Investigational Site, Seongnam-si,, 463-707, Korea, Republic of|GSK Investigational Site, Seoul, 143-729, Korea, Republic of|GSK Investigational Site, Saltillo, Coahuila, 25000, Mexico|GSK Investigational Site, Monterrey, Nuevo León, 64660, Mexico|GSK Investigational Site, Mexico, 14000, Mexico|GSK Investigational Site, Auckland, 0622, New Zealand|GSK Investigational Site, Karachi, 74800, Pakistan|GSK Investigational Site, Lahore, 54000, Pakistan|GSK Investigational Site, Lahore, 54590, Pakistan|GSK Investigational Site, Lima, Lima 13, Peru|GSK Investigational Site, Pasig City, 1600, Philippines|GSK Investigational Site, Quezon City, 1102, Philippines|GSK Investigational Site, Cabo Rojo, 623, Puerto Rico|GSK Investigational Site, San Juan, 00918, Puerto Rico|GSK Investigational Site, San Juan, 90660, Puerto Rico|GSK Investigational Site, Moscow, 115522, Russian Federation|GSK Investigational Site, Moscow, 115552, Russian Federation|GSK Investigational Site, Moscow, 117049, Russian Federation|GSK Investigational Site, St. Petersburg, 197022, Russian Federation|GSK Investigational Site, St.-Petersburg, 198103, Russian Federation|GSK Investigational Site, Bradford, BD3 0DQ, United Kingdom|GSK Investigational Site, Derriford, Plymouth, PL6 8BX, United Kingdom|GSK Investigational Site, West of Scotland Science Park, Glasgow, G20 0XA, United Kingdom Less << |
NCT00242619 | Depression Bi... More >>polar Disorder Insulin Resistance Less << | Not Applicable | Completed | - | United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less << |
NCT00490568 | - | Terminated(Based on preliminar... More >>y parent study results) Less << | - | - | |
NCT00135330 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, Arizona ... More >> Research Site Phoenix, Arizona, United States United States, California Research Site San Francisco, California, United States United States, Florida Research Site Jacksonville, Florida, United States Research Site Orlando, Florida, United States United States, Georgia Research Site Atlanta, Georgia, United States United States, Hawaii Research Site Honolulu, Hawaii, United States United States, Indiana Research Site Indianapolis, Indiana, United States United States, Massachusetts Research Site Boston, Massachusetts, United States Research Site Pittsfield, Massachusetts, United States United States, Minnesota Research Site Minneapolis, Minnesota, United States Research Site Rochester, Minnesota, United States United States, New York Research Site Bronx, New York, United States Research Site Syracuse, New York, United States United States, Ohio Research Site Cincinatti, Ohio, United States United States, Texas Research Site League City, Texas, United States Research Site New Braunfels, Texas, United States Research Site San Antonio, Texas, United States United States, Washington Research Site Renton, Washington, United States Research Site Spokane, Washington, United States Less << |
NCT00490568 | Alzheimer's Disease | Phase 3 | Terminated(Based on preliminar... More >>y parent study results) Less << | - | - |
NCT00333723 | Diabetes Mellitus, Type 2 | PHASE4 | COMPLETED | 2003-01-06 | - |
NCT00349427 | Type 2 Diabetes Mellitus ... More >> Diabetes Mellitus, Type 2 Less << | Phase 3 | Completed | - | China, Jiangsu ... More >> GSK Investigational Site Nanjing, Jiangsu, China, 210008 China, Shanxi GSK Investigational Site Xian, Shanxi, China, 710032 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100034 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Beijing, China, 100853 GSK Investigational Site Shanghai, China, 200001 GSK Investigational Site Shanghai, China, 200032 GSK Investigational Site Shanghai, China, 200233 GSK Investigational Site Tianjin, China, 300052 Less << |
NCT00265148 | Alzheimer's Disease | Phase 2 | Completed | - | United States, Arizona ... More >> GSK Investigational Site Litchfield Park, Arizona, United States, 85340 GSK Investigational Site Phoenix, Arizona, United States, 85006 GSK Investigational Site Scottsdale, Arizona, United States, 85259 GSK Investigational Site Sun City, Arizona, United States, 85351 GSK Investigational Site Tucson, Arizona, United States, 85724 United States, California GSK Investigational Site Los Angeles, California, United States, 90024 United States, Massachusetts GSK Investigational Site Belmont, Massachusetts, United States, 02478 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H3T 1E2 GSK Investigational Site Montreal, Quebec, Canada, H4H 1R3 United Kingdom GSK Investigational Site Liverpool, United Kingdom, L9 7LJ GSK Investigational Site Manchester, United Kingdom, M20 3LJ GSK Investigational Site Swindon, United Kingdom, SN1 4HZ GSK Investigational Site West End, Southampton, United Kingdom, SO30 3JB Less << |
NCT00135330 | - | Completed | - | - | |
NCT00612066 | Cushing's Disease | Phase 2 | Terminated(Low accrual and fun... More >>ding term ended) Less << | - | United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less << |
NCT00612066 | - | Terminated(Low accrual and fun... More >>ding term ended) Less << | - | - | |
NCT01574820 | Prediabetes C... More >>oronary Artery Disease Insulin Resistance Glucose Intolerance Less << | Phase 3 | Completed | - | - |
NCT00274495 | Chronic Hepatitis C Infection ... More >> Fatty Liver Less << | Phase 4 | Terminated | - | United States, New York ... More >> Beth Israel Medical Center - Philipps Ambulatory Care Center New York, New York, United States, 10003 Less << |
NCT00523913 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00413335 | - | Completed | - | - | |
NCT00500955 | Diabetes Mellitus, Type 2 | PHASE3 | COMPLETED | 2025-06-04 | GSK Investigational Site, Birm... More >>ingham, Alabama, 35211, United States|GSK Investigational Site, Tempe, Arizona, 85282, United States|GSK Investigational Site, Fullerton, California, 92835, United States|GSK Investigational Site, Long Beach, California, 90806, United States|GSK Investigational Site, Mission Viejo, California, 92691, United States|GSK Investigational Site, Pasadena, California, 91105, United States|GSK Investigational Site, Redwood City, California, 94062, United States|GSK Investigational Site, San Diego, California, 92108, United States|GSK Investigational Site, San Diego, California, 92128, United States|GSK Investigational Site, Santa Barbara, California, 93105, United States|GSK Investigational Site, Tustin, California, 92780, United States|GSK Investigational Site, Ukiah, California, 95482, United States|GSK Investigational Site, Denver, Colorado, 80209, United States|GSK Investigational Site, Denver, Colorado, 80220, United States|GSK Investigational Site, New Britain, Connecticut, 06050, United States|GSK Investigational Site, Norwalk, Connecticut, 06850, United States|GSK Investigational Site, Newark, Delaware, 19713, United States|GSK Investigational Site, Jacksonville, Florida, 32204, United States|GSK Investigational Site, Miami, Florida, 33136, United States|GSK Investigational Site, Winter Park, Florida, 32789, United States|GSK Investigational Site, Blue Ridge, Georgia, 30513, United States|GSK Investigational Site, Chicago, Illinois, 60612, United States|GSK Investigational Site, Peoria, Illinois, 61615, United States|GSK Investigational Site, Indianapolis, Indiana, 46201, United States|GSK Investigational Site, South Bend, Indiana, 46601, United States|GSK Investigational Site, Slidell, Louisiana, 70458, United States|GSK Investigational Site, Baltimore, Maryland, 21208, United States|GSK Investigational Site, Boston, Massachusetts, 02215, United States|GSK Investigational Site, Springfield, Massachusetts, 01199, United States|GSK Investigational Site, Royal Oak, Michigan, 48073, United States|GSK Investigational Site, Brooklyn Center, Minnesota, 55430, United States|GSK Investigational Site, St. Louis, Missouri, 63141, United States|GSK Investigational Site, Henderson, Nevada, 89014, United States|GSK Investigational Site, Las Vegas, Nevada, 89103, United States|GSK Investigational Site, Albuquerque, New Mexico, 87106, United States|GSK Investigational Site, Albany, New York, 12206, United States|GSK Investigational Site, Binghamton, New York, 13903, United States|GSK Investigational Site, Endwell, New York, 13760, United States|GSK Investigational Site, New York, New York, 10010, United States|GSK Investigational Site, Portland, Oregon, 97232, United States|GSK Investigational Site, Hermitage, Pennsylvania, 16148, United States|GSK Investigational Site, Philadelphia, Pennsylvania, 19124, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, 15221, United States|GSK Investigational Site, Columbia, South Carolina, 29201, United States|GSK Investigational Site, Beaumont, Texas, 77701, United States|GSK Investigational Site, Dallas, Texas, 75230, United States|GSK Investigational Site, Houston, Texas, 77027, United States|GSK Investigational Site, Houston, Texas, 77030, United States|GSK Investigational Site, Houston, Texas, 77074, United States|GSK Investigational Site, San Antonio, Texas, 78207, United States|GSK Investigational Site, San Antonio, Texas, 78237, United States|GSK Investigational Site, Richmond, Virginia, 23249, United States|GSK Investigational Site, Edmonds, Washington, 98026, United States|GSK Investigational Site, Spokane, Washington, 99204, United States|GSK Investigational Site, Madison, Wisconsin, 53792, United States|GSK Investigational Site, Milwaukee, Wisconsin, 53209-0996, United States|GSK Investigational Site, Vienna, A-1030, Austria|GSK Investigational Site, Vienna, A-1090, Austria|GSK Investigational Site, Vienna, A-1140, Austria|GSK Investigational Site, Vancouver, British Columbia, V6Z 2K8, Canada|GSK Investigational Site, Winnipeg, Manitoba, R3A 1R9, Canada|GSK Investigational Site, North Bay, Ontario, P1B 2H3, Canada|GSK Investigational Site, Ottawa, Ontario, K1H 7W9, Canada|GSK Investigational Site, Peterborough, Ontario, K9J 7B3, Canada|GSK Investigational Site, Smiths Falls, Ontario, K7A 2H6, Canada|GSK Investigational Site, Toronto, Ontario, M5C 2T2, Canada|GSK Investigational Site, Laval, Quebec, H7T 2P5, Canada|GSK Investigational Site, Montreal, Quebec, H1T 2M4, Canada|GSK Investigational Site, Sainte-Foy, Quebec, G1V 4G2, Canada|GSK Investigational Site, Santiago, Región Metro De Santiago, 7510605, Chile|GSK Investigational Site, Santiago, Región Metro De Santiago, Chile|GSK Investigational Site, Vi?a del Mar, Valparaíso, Chile|GSK Investigational Site, Koenigsfeld, Baden-Wuerttemberg, 78126, Germany|GSK Investigational Site, Unterschneidheim, Baden-Wuerttemberg, 73485, Germany|GSK Investigational Site, Grafing, Bayern, 85567, Germany|GSK Investigational Site, Frankfurt, Hessen, 60596, Germany|GSK Investigational Site, Borna, Sachsen, 04552, Germany|GSK Investigational Site, Delitzsch, Sachsen, 04509, Germany|GSK Investigational Site, Dresden, Sachsen, 01307, Germany|GSK Investigational Site, Goerlitz, Sachsen, 02826, Germany|GSK Investigational Site, Leipzig, Sachsen, 04107, Germany|GSK Investigational Site, Apolda, Thueringen, 99510, Germany|GSK Investigational Site, Jelgava, LV 3001, Latvia|GSK Investigational Site, Riga, LV 1006, Latvia|GSK Investigational Site, Riga, LV1002, Latvia|GSK Investigational Site, Riga, LV1079, Latvia|GSK Investigational Site, Talsi, LV 3201, Latvia|GSK Investigational Site, Valmiera, LV 4201, Latvia|GSK Investigational Site, Guadalajara, Jalisco, 44340, Mexico|GSK Investigational Site, Durango, 3400, Mexico|GSK Investigational Site, Mexico, 14080, Mexico|GSK Investigational Site, Amersfoort, 3818 ES, Netherlands|GSK Investigational Site, Leiden, 2331 JE, Netherlands|GSK Investigational Site, Rotterdam, 3021 HC, Netherlands|GSK Investigational Site, Zwaag, 1689 PZ, Netherlands|GSK Investigational Site, Banska Bystrica, 975 17, Slovakia|GSK Investigational Site, Bratislava, 813 69, Slovakia|GSK Investigational Site, Martin, 036 59, Slovakia|GSK Investigational Site, Alicante, Spain|GSK Investigational Site, Granada, 18003, Spain|GSK Investigational Site, Madrid, 28035, Spain|GSK Investigational Site, Madrid, 28041, Spain|GSK Investigational Site, Madrid, 28046, Spain|GSK Investigational Site, Madrid, 28047, Spain|GSK Investigational Site, Sagunto/Valencia, 46520, Spain|GSK Investigational Site, Santiago De Compostela, 15705, Spain|GSK Investigational Site, Liverpool, Merseyside, L7 8XP, United Kingdom|GSK Investigational Site, Edinburgh, Midlothian, EH3 9YW, United Kingdom|GSK Investigational Site, Paisley, Renfrewshire, PA2 9PN, United Kingdom|GSK Investigational Site, Bath, Somerset, BA1 3NG, United Kingdom|GSK Investigational Site, Livingston, West Lothian, EH54 6PP, United Kingdom|GSK Investigational Site, Gateshead, NE9 6SX, United Kingdom|GSK Investigational Site, Newport, PO30 5TG, United Kingdom Less << |
NCT00413335 | Obesity Impai... More >>red Glucose Tolerance Type 2 Diabetes Mellitus Less << | Not Applicable | Completed | - | United States, Connecticut ... More >> Yale School of Medicine New Haven, Connecticut, United States, 06520 Less << |
NCT00688207 | Alzheimer's Disease | Phase 1 | Completed | - | Germany ... More >> GSK Investigational Site Berlin, Germany, 10117 Less << |
NCT01872780 | Healthy | Phase 1 | Completed | - | - |
NCT00290394 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Turkey ... More >> Baskent University Ankara Hospital Ankara, Turkey, 06490 Less << |
NCT01376063 | Healthy Adult Subjects | Phase 1 | Completed | - | - |
NCT00285805 | Insulin Resistance | Not Applicable | Completed | - | Netherlands ... More >> Radboud University Nijmegen medical centre Nijmegen, Netherlands, 6500 HB Less << |
NCT00004180 | Sarcoma | Phase 2 | Completed | - | United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less << |
NCT00733174 | Impaired Glucose Tolerance | Phase 4 | Unknown | - | United States, Colorado ... More >> South Federal Family Practice Recruiting Denver, Colorado, United States, 80219 Contact: Annette Grissett, MA 303-934-2202 annetteg@roydurbin.com Contact: Stacey Mitchell, BSN, RN 303-399-8020 ext 2059 stacey.mitchell@va.gov Less << |
NCT01209143 | Solid Cancers | Phase 1 | Completed | - | United States, California ... More >> Stanford, California, United States, 94305 United States, Michigan Detroit, Michigan, United States, 48201 United States, Texas Houston, Texas, United States, 77030 Less << |
NCT01209143 | - | Completed | - | - | |
NCT00614874 | - | Completed | - | - | |
NCT01453049 | - | Terminated(US FDA/EMA/SFDA dec... More >>isions to rosiglitazone-containing medicines, ethic) Less << | - | - | |
NCT00381238 | Alzheimer's Disease | Phase 2 | Completed | - | United States, Arizona ... More >> GSK Investigational Site Litchfield Park, Arizona, United States, 85340 GSK Investigational Site Phoenix, Arizona, United States, 85006 GSK Investigational Site Sun City, Arizona, United States, 85351 United States, Massachusetts GSK Investigational Site Belmont, Massachusetts, United States, 02478 United States, Michigan GSK Investigational Site Ann Arbor, Michigan, United States, 48109 United States, North Carolina GSK Investigational Site Durham, North Carolina, United States, 27705 Canada, Quebec GSK Investigational Site Montreal, Quebec, Canada, H4H 1R3 Less << |
NCT00381238 | - | Completed | - | - | |
NCT00424762 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | United States, Texas ... More >> University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390-9034 Less << |
NCT00306176 | Type II Diabetes Mellitus | PHASE4 | COMPLETED | 2025-10-06 | AHEPA University Hospital of T... More >>hessaloniki, Thessaloniki, 54454, Greece Less << |
NCT01453049 | Diabetes Mellitus, Type 2 | Phase 3 | Terminated(US FDA/EMA/SFDA dec... More >>isions to rosiglitazone-containing medicines, ethic) Less << | - | China, Hubei ... More >> GSK Investigational Site Wuhan, Hubei, China, 430030 China, Jiangsu GSK Investigational Site Suzhou, Jiangsu, China, 215004 China, Liaoning GSK Investigational Site Dalian, Liaoning, China, 116027 China, Zhejiang GSK Investigational Site Hangzhou, Zhejiang, China, 310003 GSK Investigational Site Hangzhou, Zhejiang, China, 310009 China GSK Investigational Site Beijing, China, 100029 GSK Investigational Site Beijing, China, 100730 GSK Investigational Site Chongqing, China, 400016 GSK Investigational Site Shanghai, China, 200080 GSK Investigational Site Shenyang, China, 110003 GSK Investigational Site Tianjin, China, 300052 GSK Investigational Site Wuhan, China, 430022 Less << |
NCT00231387 | Non-insulin-dependent Diabetes... More >> Mellitus Less << | Phase 3 | Completed | - | United Kingdom ... More >> GSK Clinical Trials Call Center London, United Kingdom, W2 1NY Less << |
NCT01195259 | - | Completed | - | - | |
NCT00424762 | - | Completed | - | - | |
NCT00337350 | Schizophrenia | Phase 4 | Completed | - | United States, Massachusetts ... More >> Massachusetts General Hospital Schizophrenia Program Boston, Massachusetts, United States, 02114 Less << |
NCT00337350 | - | Completed | - | - | |
NCT00367744 | - | Completed | - | - | |
NCT01415128 | Erectile Dysfunction | Phase 1 | Completed | - | - |
NCT00367744 | HIV Infections | Phase 2 | Completed | - | United States, Ohio ... More >> Cleveland Clinc Foundation Cleveland, Ohio, United States, 44106 University Hospitals of Cleveland/Case Western Reserve University Cleveland, Ohio, United States, 44141 Less << |
NCT00616642 | Brain and Central Nervous Syst... More >>em Tumors Less << | Phase 2 | Terminated(low patient recruit... More >>ment) Less << | - | United States, California ... More >> Jonsson Comprehensive Cancer Center at UCLA Los Angeles, California, United States, 90095-1781 Less << |
NCT00369174 | Oral Leukoplakia | Phase 2 | Completed | - | United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less << |
NCT00614874 | Asthma | Phase 2 | Completed | - | United States, Nebraska ... More >> Creighton University Medical Center, Department of Pulmonology and Critical Care Omaha, Nebraska, United States, 68131 Less << |
NCT00207402 | Hepatitis C | Phase 4 | Completed | - | United States, Texas ... More >> Brooke Army Medical Center Ft. Sam Houston, Texas, United States, 78234 Less << |
NCT01150981 | Metabolic Syndrome ... More >> Insulin Resistance Less << | Phase 2 | Completed | - | United States, Massachusetts ... More >> UMass Medical School Worcester, Massachusetts, United States, 01655 Less << |
NCT00242593 | Mild Cognitive Impairment | PHASE2 | UNKNOWN | 2025-12-11 | Banner Alzheimer Institute, Ph... More >>oenix, Arizona, 85006, United States|UCLA Alzheimer's Disease Center, Los Angeles, California, 90095, United States|University of Washington/VA Puget Sound Health Care System, Seattle/Tacoma, Washington, 98108, United States Less << |
NCT01045590 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | Korea, Republic of ... More >> GSK Investigational Site Seoul, Korea, Republic of, 110-744 GSK Investigational Site Seoul, Korea, Republic of, 120-752 GSK Investigational Site Seoul, Korea, Republic of, 135-710 GSK Investigational Site Seoul, Korea, Republic of, 137-701 Less << |
NCT00065065 | Ulcerative Colitis ... More >> Inflammatory Bowel Disease Less << | Phase 2 | Completed | - | United States, Georgia ... More >> Atlanta Gastroenterology Associates Atlanta, Georgia, United States, 30342 United States, Illinois University of Chicago Hospitals Chicago, Illinois, United States, 60637 United States, Maryland Metropolitan Gastroenterology Group Practice/Chevy Chase Clinical Research Chevy Chase, Maryland, United States, 20815 Maryland Digestive Diseases Research Laurel, Maryland, United States, 20707 Capitol Gastroenterology Consultants Silver Spring, Maryland, United States, 20901 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota Minnesota Gastroenterology Plymouth, Minnesota, United States, 55446 United States, New Jersey Atlantic Gastroenterology Associates Egg Harbor Township, New Jersey, United States, 08234 United States, North Carolina Wake Research Associates Raleigh, North Carolina, United States, 27612 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 The Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 Avamar Center for Endoscopy Warren, Ohio, United States, 44484 United States, Pennsylvania University of Pennsylvania - Presbyterian Medical Center Philadelphia, Pennsylvania, United States, 19104 Less << |
NCT01150981 | - | Completed | - | - | |
NCT00065065 | - | Completed | - | - | |
NCT00819910 | Hypertriglyceridemia in Type 4... More >> Hyperlipidemia Non Diabetic Subjects With Normoglycemia Less << | Phase 4 | Terminated(Slow recruitment an... More >>d increase in deployment overseas limiting follow up) Less << | - | United States, Texas ... More >> Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less << |
NCT00169832 | Diabetes Coro... More >>nary Artery Bypass Grafting Less << | Phase 3 | Completed | - | Canada, Nova Scotia ... More >> QEII Health Sciences Center - Halifax Infirmary Halifax, Nova Scotia, Canada, B3H 3A7 Canada, Ontario Hamilton Health Sciences - Mc Master Clinic Hamilton, Ontario, Canada, L8L 2X2 Toronto General Hospital Toronto, Ontario, Canada, M5G 2C4 Canada, Quebec CRMSBC Bonaventure, Quebec, Canada, G0C 1E0 CHUM Notre-Dame Hospital Montreal, Quebec, Canada, H2L 4M1 Laval Hospital Sainte-Foy, Quebec, Canada, G1V 4G5 Spain Hospital Del Mar Barcelona, Spain Hospital Universitari Vall D'Hebron Barcelona, Spain Hospital Universitarion Son Dureta Palma de Mallorca, Spain Less << |
NCT00616642 | - | Terminated(low patient recruit... More >>ment) Less << | - | - | |
NCT00370305 | Metabolic Syndrome ... More >> Impaired Glucose Tolerance Less << | Phase 2 | Completed | - | Germany ... More >> Charite, Campus Benjamin Franklin Berlin, Germany, 12200 Less << |
NCT00609362 | - | Completed | - | - | |
NCT00746174 | Insulin Sensitivity | Phase 4 | Completed | - | United States, Texas ... More >> University of Texas Southwestern Medical Center at Dallas Dallas, Texas, United States, 75390 Less << |
NCT00405015 | Ischemia-Reperfusion Injury ... More >> The Metabolic Syndrome Less << | Phase 2 | Completed | - | Netherlands ... More >> Clinical research Center Nijmegen Nijmegen, Netherlands, 6500 HB Less << |
NCT00819910 | - | Terminated(Slow recruitment an... More >>d increase in deployment overseas limiting follow up) Less << | - | - | |
NCT01577095 | Type 2 Diabetes Mellitus With ... More >>Features of Insulin Resistance Less << | Phase 2 | Completed | - | Taiwan ... More >> Department of Integrative Chinese-Western Clinic, China Medical University Hospital Taichung, Taiwan, 404 Less << |
NCT00609362 | Change in Bone Mineral Density... More >> Change in Bone Marrow Fat Content Less << | Phase 2 | Completed | - | Denmark ... More >> Aarhus University Hospital Aarhus, Denmark, 8000 C Less << |
NCT00486187 | Type 2 Diabetes Mellitus | Not Applicable | Completed | - | Canada, Ontario ... More >> Partners Research Brampton, Ontario, Canada, L6V 1B4 Less << |
NCT01406704 | NASH (Non-alcoholic Steato-hep... More >>atitis) Less << | Phase 4 | Terminated(because of withdraw... More >>al of Avandia sale due to its risks outweigh its benefits) Less << | December 2013 | - |
NCT02526615 | Insulin Sensitivity ... More >> Type 2 Diabetes Less << | Phase 4 | Completed | - | Finland ... More >> Turku PET Centre Turku, Finland, 20520 Turku university hospital, PET center Turku, Finland, 20520 Turku PET Centre (Turku University Hospital) Turku, Finland, 20521 Less << |
NCT00785213 | Healthy | Phase 1 | Completed | - | United States, Minnesota ... More >> Cetero Research East Grand Forks, Minnesota, United States, 56721 Less << |
NCT00182052 | Adenocarcinoma of the Prostate... More >> Prostate Cancer Less << | Phase 3 | Completed | - | United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less << |
NCT01706211 | Diabetes Mellitus Non Insulin ... More >>Dependent Oral Agent Therapy Less << | Phase 3 | Completed | - | Taiwan ... More >> National Taiwan University Hospital Taipei, Taiwan, 10002 Less << |
NCT01100619 | Papillary Thyroid Cancer ... More >> Follicular Thyroid Cancer Huerthle Cell Thyroid Cancer Renal Cell Carcinoma Less << | Phase 1 | Completed | - | United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Montefiore Medical Center Bronx, New York, United States, 10466 United States, Pennsylvania Hospital of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77230 Less << |
NCT03309319 | Pituitary Tumor | UNKNOWN | 2018-12-31 | Huashan Hospital, Shanghai, Sh... More >>anghai, 200040, China Less << | |
NCT00785213 | - | Completed | - | - | |
NCT02694874 | Malaria | Not Applicable | Recruiting | December 2019 | Mozambique ... More >> Centro de Investigação em Saude da Manhiça Recruiting Manhiça, Maputo, Mozambique, CP1929 Contact: Quique Bassat, PhD Contact: Eusebio Macete, PhD Less << |
NCT03492580 | - | Completed | - | United States, New Jersey ... More >> Janssen Investigative Site Titusville, New Jersey, United States, 08560 Less << | |
NCT00975286 | - | Completed | - | - | |
NCT00975286 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT02456428 | - | Completed | - | Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less << | |
NCT02475499 | - | Completed | - | Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less << | |
NCT00000620 | Atherosclerosis ... More >> Cardiovascular Diseases Hypercholesterolemia Hypertension Diabetes Mellitus, Type 2 Diabetes Mellitus Coronary Disease Less << | Phase 3 | Completed | - | United States, Minnesota ... More >> Minneapolis Medical Research Foundation Minneapolis, Minnesota, United States, 55404 United States, New York Columbia University New York, New York, United States, 10027 United States, North Carolina Wake Forest University Winston-Salem, North Carolina, United States, 27106 United States, Ohio Case Western Reserve University Cleveland, Ohio, United States, 44106 United States, Tennessee Veterans Affairs Memphis, Tennessee, United States, 38104 United States, Washington University of Washington Seattle, Washington, United States, 98195 Canada, Ontario McMaster University Hamilton, Ontario, Canada Less << |
NCT00885352 | Type 2 Diabetes Mellitus | Phase 3 | Completed | - | - |
NCT00885352 | - | Completed | - | - | |
NCT00814255 | - | Completed | - | - | |
NCT00950534 | Diabetes Mellitus, Type 2 | Phase 4 | Terminated(due to poor recruit... More >>ment) Less << | - | Australia ... More >> Sanofi-Aventis Administrative Office Macquarie Park, Australia Less << |
NCT02476760 | - | Completed | - | Canada, Quebec ... More >> Lady Davis Institute for Medical Research, Jewish General Hospital Montreal, Quebec, Canada, H3T1E2 Less << | |
NCT00000620 | - | Completed | - | - | |
NCT00386100 | Diabetes Mellitus, Type 2 | Phase 4 | Completed | - | - |
NCT00481663 | Type II Diabetes Mellitus | Phase 2 | Completed | - | - |
NCT00341406 | - | Completed | - | United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Disorders (NIDDK), 9000 Bethesda, Maryland, United States, 20892 Less << | |
NCT00814255 | Focal Segmental Glomeruloscler... More >>osis Less << | Phase 2 | Completed | - | United States, Florida ... More >> University of Miami Miami, Florida, United States, 33136 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Kansas University of Kansas Kansas City, Kansas, United States, 66160 United States, Massachusetts Boston Children's Hospital Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55901 United States, Missouri Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Cardinal Glennon Children's Medical Center Saint Louis, Missouri, United States, 63104 United States, New York Steven and Alexandra Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 NYU Langone Medical Center New York, New York, United States, 10016 Columbia University Medical Center New York, New York, United States, 10032 United States, North Carolina Carolinas Medical Center Charlotte, North Carolina, United States, 28207 United States, Ohio Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Ohio State University Columbus, Ohio, United States, 43205 United States, Oregon Doernbecher Children's Hospital Portland, Oregon, United States, 97239 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Texas Tech University El Paso, Texas, United States, 79905 Canada, Alberta University of Alberta Edmonton, Alberta, Canada, T6G 2R7 Less << |
NCT00386100 | - | Completed | - | - | |
NCT00376870 | Coronary Atherosclerosis ... More >> Coronary Restenosis Diabetes Less << | Phase 3 | Unknown | April 2011 | Italy ... More >> Policlinico di Tor Vergata Not yet recruiting Rome, Italy, 00133 Principal Investigator: Fabrizio Clementi, MD. PhD Policlinico di Tor Vergata Recruiting Rome, Italy, 00133 Contact: Saverio Muscoli, MD +390620904009 fabrizio.clementi@me.com Principal Investigator: Fabrizio Clementi, MD, PhD Less << |
NCT00732121 | Type 2 Diabetes | Phase 4 | Unknown | August 2010 | United States, Vermont ... More >> University of Vermont South Burlington, Vermont, United States, 05403 Less << |
NCT00964106 | Drug Interactions | Phase 1 | Completed | - | Korea, Republic of ... More >> GSK Investigational Site Busan, Korea, Republic of, 614-735 GSK Investigational Site Seoul, Korea, Republic of, 110-744 Less << |
NCT01408862 | - | Completed | - | - | |
NCT01408862 | - | Completed | - | - | |
NCT01909141 | Polycystic Ovary Syndrome ... More >> Infertility Less << | Early Phase 1 | Completed | - | Egypt ... More >> Cairo University Cairo, Egypt Less << |
NCT00467285 | - | Completed | - | - | |
NCT00467285 | - | Completed | - | - | |
NCT02285205 | Type 2 Diabetes ... More >> Non-alcoholic Fatty Liver Disease Less << | Phase 4 | Completed | - | Korea, Republic of ... More >> Severance Hospital, Department of Internal Medicine, Yonsei University College of Medicine Seoul, Korea, Republic of, 120-752 Less << |
NCT02341703 | Polycystic Ovary Syndrome ... More >> Infertility Less << | Early Phase 1 | Completed | - | Egypt ... More >> faculty of medicine, Cairo University Cairo, Egypt, 002 Less << |
NCT01909141 | - | Completed | - | - | |
NCT00099853 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less << |
NCT00015626 | Insulin Resistance ... More >> Diabetes Mellitus Less << | Phase 2 | Completed | - | United States, New York ... More >> Cornell University New York, New York, United States, 10021 Less << |
NCT01175486 | Diabetes | Phase 4 | Unknown | December 2015 | Taiwan ... More >> Taipei Veterans General Hospital, Taiwan Recruiting Taipei, Taiwan Principal Investigator: Harn-Shen Chen, MD, PhD Less << |
NCT00357370 | - | Completed | - | - | |
NCT00364988 | Type 2 Diabetes ... More >> Diabetic Nephropathy Less << | Not Applicable | Completed | - | - |
NCT00357370 | Type 2 Diabetes | Phase 2 Phase 3 | Completed | - | - |
NCT00926016 | Chronic Hepatitis C | Not Applicable | Completed | - | United States, Texas ... More >> Brooke Army Medical Center San Antonio, Texas, United States, 78234 Less << |
NCT00138554 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less << |
NCT00293137 | - | Terminated(safety concerns reg... More >>arding use of rosiglitazone) Less << | - | United States, Ohio ... More >> Cleveland Clinic Cleveland, Ohio, United States, 44195 Less << | |
NCT00745914 | Endstage Renal Disease ... More >> Diabetes Less << | Not Applicable | Completed | - | Hong Kong ... More >> Queen Mary Hospital and Tung Wah Hospital Hong Kong, Hong Kong, 0000 Queen Mary Hospital, Tung Wah Hospital Hong Kong, Hong Kong, 0000 Less << |
NCT00359112 | Non-Insulin-Dependent Diabetes... More >> Mellitus Less << | Phase 3 | Completed | - | - |
NCT00295633 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | - |
NCT00680745 | Type 2 Diabetes | Phase 3 | Completed | - | - |
NCT00295633 | - | Completed | - | - | |
NCT01055223 | - | Completed | - | - | |
NCT00396227 | Diabetes Mellitus, Type 2 | Phase 3 | Completed | - | United States, New Jersey ... More >> Novartis Pharmaceuticals East Hanover, New Jersey, United States, 07936 Less << |
NCT00680745 | - | Completed | - | - | |
NCT00742326 | - | Terminated(Enrollment stopped ... More >>prior to complete enrollment due to slow accrual) Less << | - | - | |
NCT01055223 | - | Completed | - | - | |
NCT00776607 | Latent Autoimmune Diabetes in ... More >>Adults LADA Less << | Not Applicable | Unknown | April 2011 | United Kingdom ... More >> Diabetes Unit Not yet recruiting Cardiff, Wales, United Kingdom, CF64 2XX Contact: Julia Platts 02920 711 711 ext 5149 Julia.Platts@CardiffandVale.wales.nhs.uk Principal Investigator: Julia Platts Clinical Research Unit Recruiting Swansea, Wales, United Kingdom, SA6 6NL Contact: Lucy Barlow +44 (0) 1792 703722 ext 3722 Lucy.Barlow@swansea-tr.wales.nhs.uk Principal Investigator: Jeffrey Stephens Less << |
NCT00636766 | Carotid Atherosclerosis ... More >> Stroke Type 2 Diabetes Metabolic Syndrome Less << | Not Applicable | Completed | - | Greece ... More >> General Hospital of Thessaloniki "Hippokratio" Thessaloniki, Greece Less << |
NCT00742326 | HIV Hepatitis... More >> C Liver Disease Fatty Liver Steatosis Less << | Phase 4 | Terminated(Enrollment stopped ... More >>prior to complete enrollment due to slow accrual) Less << | - | United States, District of Col... More >>umbia VA Medical Center Washington, District of Columbia, United States, 20422 United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less << |
NCT00692510 | Metabolism Al... More >>zheimer's Disease Less << | Phase 1 | Completed | - | Sweden ... More >> Research Site Uppsala, Sweden Less << |
NCT02737709 | Non-small Cell Lung Cancer | Phase 2 | Terminated(The study have diff... More >>iculty in recruiting subjectes) Less << | - | China, Guangdong ... More >> Sun Yat-sen University Cancer Center Guangzhou, Guangdong, China, 510060 Less << |
NCT00437970 | Diabetes Mellitus, Type 2 | Phase 4 | Withdrawn(Unable to secure sup... More >>ply of the study medication) Less << | February 2009 | Australia, Northern Territory ... More >> Menzies School of Health Research Darwin, Northern Territory, Australia, 0810 Less << |
NCT00232362 | Type 2 Diabetes Mellitus | Phase 1 | Withdrawn(This study was not c... More >>onducted as the Principal Investigator left the institution) Less << | June 2008 | - |
NCT00443170 | Healthy Subjects ... More >> Anaemia Less << | Phase 1 | Completed | - | Australia, New South Wales ... More >> GSK Investigational Site Randwick, Sydney, New South Wales, Australia, 2031 Australia, Queensland GSK Investigational Site Herston, Queensland, Australia, 4006 Australia, South Australia GSK Investigational Site Adelaide, South Australia, Australia, 5000 Less << |
NCT00225355 | Angina Pectoris|Metabolic Synd... More >>rome X Less << | PHASE4 | TERMINATED | 2025-11-06 | Cardiology Department, Glasgow... More >> Royal Infirmary, Glasgow, G4 0SF, United Kingdom Less << |
NCT00297063 | Diabetes Mellitus, Type 2 | PHASE3 | COMPLETED | 2007-05-31 | GSK Investigational Site, Fuku... More >>oka, 819-0168, Japan|GSK Investigational Site, Fukushima, 962-0856, Japan|GSK Investigational Site, Hokkaido, 051-0005, Japan|GSK Investigational Site, Ibaraki, 311-0113, Japan|GSK Investigational Site, Kanagawa, 224-0024, Japan|GSK Investigational Site, Kyoto, 615-0035, Japan|GSK Investigational Site, Nagano, 399-0006, Japan|GSK Investigational Site, Osaka, 577-0803, Japan|GSK Investigational Site, Saitama, 349-1105, Japan|GSK Investigational Site, Shizuoka, 424-0855, Japan|GSK Investigational Site, Tokyo, 125-0054, Japan|GSK Investigational Site, Tokyo, 130-0004, Japan|GSK Investigational Site, Tokyo, 160-0017, Japan|GSK Investigational Site Less << |
NCT00240604 | Glucose Intolerance | PHASE3 | UNKNOWN | 2025-10-15 | Hadassah Medical Organization,... More >> Jerusalem, 91120, Israel Less << |
NCT00256646 | Type 2 Diabetes Mellitus | COMPLETED | 2025-05-08 | Carl T. Hayden VA Medical Cent... More >>er, Phoenix, Arizona, 85012, United States|Southern Arizona VA Health Care System, Tucson, Tucson, Arizona, 85723, United States|VA Central California Health Care System, Fresno, Fresno, California, 93703, United States|VA Medical Center, Long Beach, Long Beach, California, 90822, United States|VA San Diego Healthcare System, San Diego, San Diego, California, 92161, United States|Miami VA Healthcare System, Miami, FL, Miami, Florida, 33125, United States|Edward Hines, Jr. VA Hospital, Hines, Illinois, 60141-5000, United States|Richard Roudebush VA Medical Center, Indianapolis, Indianapolis, Indiana, 46202-2884, United States|VA Medical Center, Lexington, Lexington, Kentucky, 40502, United States|VA Medical Center, Minneapolis, Minneapolis, Minnesota, 55417, United States|VA Medical Center, Omaha, Omaha, Nebraska, 68105-1873, United States|VA New Jersey Health Care System, East Orange, East Orange, New Jersey, 07018, United States|VA Pittsburgh Health Care System, Pittsburgh, Pennsylvania, 15240, United States|Michael E. DeBakey VA Medical Center (152), Houston, Texas, 77030, United States|VA South Texas Health Care System, San Antonio, San Antonio, Texas, 78229, United States|VA Medical Center, Salem VA, Salem, Virginia, 24153, United States|VA Medical Center, San Juan, San Juan, 00921, Puerto Rico Less << | |
NCT00121953 | Endometriosis | PHASE2|PHASE3 | WITHDRAWN | 2025-05-08 | University of Michigan Health ... More >>System, Ann Arbor, Michigan, 48109, United States Less << |
NCT00006493 | HIV Infections|Hyperlipidemia | PHASE2 | COMPLETED | - | Division of Endocrinology, New... More >> York, New York, 10016, United States Less << |
NCT00409097 | Critical Illness|Multiple Orga... More >>n Failure Less << | PHASE3 | UNKNOWN | 2025-12-07 | VU University Medical Center, ... More >>Amsterdam, 1081 HV, Netherlands Less << |
NCT00995995 | Diabetes Mellitus, Type 2 | COMPLETED | 2025-02-09 | - | |
NCT00501020 | Diabetes Mellitus, Type 2 | PHASE4 | COMPLETED | 2003-02-13 | - |
NCT00440375 | Type 2 Diabetes Mellitus|Obesi... More >>ty|Menopause Less << | PHASE4 | COMPLETED | 2025-03-06 | - |
NCT00309660 | Ulcerative Colitis | PHASE1|PHASE2 | UNKNOWN | 2025-06-07 | Dept. Gastroenterology C, Herl... More >>ev University Hospital, Herlev, 2730, Denmark Less << |
NCT00481429 | Diabetes Mellitus, Type 2 | WITHDRAWN | 2025-01-08 | Addenbrooke's Hospital, Cambri... More >>dge, CB2 2GG, United Kingdom|Ealing Hospital, London, UB1 3HW, United Kingdom|Imperial College London - Hammersmith Campus, London, W12 ONN, United Kingdom|Charing Cross Hospital, London, W6 8RF, United Kingdom Less << |
Bio Calculators | ||||
Preparing Stock Solutions | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.80mL 0.56mL 0.28mL |
13.99mL 2.80mL 1.40mL |
27.98mL 5.60mL 2.80mL |